These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 10835496)
1. Changes in expression of estrogen receptors alpha and beta in relation to progesterone receptor and pS2 status in normal and malignant endometrium. Saegusa M; Okayasu I Jpn J Cancer Res; 2000 May; 91(5):510-8. PubMed ID: 10835496 [TBL] [Abstract][Full Text] [Related]
2. [Expression of estrogen and progesterone receptor subtypes in human endometrial carcinoma tissues]. Liao QP; Wu C; Zheng H; Yu L Zhonghua Fu Chan Ke Za Zhi; 2005 Nov; 40(11):752-5. PubMed ID: 16324249 [TBL] [Abstract][Full Text] [Related]
3. Expression of pS2 protein in endometrial carcinomas: correlation with clinicopathologic features and sex steroid receptor status. Koshiyama M; Yoshida M; Konishi M; Takemura M; Yura Y; Matsushita K; Hayashi M; Tauchi K Int J Cancer; 1997 Jun; 74(3):237-44. PubMed ID: 9221798 [TBL] [Abstract][Full Text] [Related]
4. Up-regulation of pS2 expression during the development of adenocarcinomas but not squamous cell carcinomas of the uterine cervix, independently of expression of c-jun or oestrogen and progesterone receptors. Saegusa M; Hashimura M; Hara A; Okayasu I J Pathol; 2000 Apr; 190(5):554-63. PubMed ID: 10727981 [TBL] [Abstract][Full Text] [Related]
6. Expression of gonadal steroid receptors in the ovaries of post-menopausal women with malignant or benign endometrial pathology: a pilot study. Panoulis K; Christantoni E; Pliatsika P; Anagnostis P; Goulis DG; Kondi-Pafiti A; Armeni E; Augoulea A; Triantafyllou N; Creatsa M; Lambrinoudaki I Gynecol Endocrinol; 2015; 31(8):613-7. PubMed ID: 26036714 [TBL] [Abstract][Full Text] [Related]
7. Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression. Lax SF; Pizer ES; Ronnett BM; Kurman RJ Hum Pathol; 1998 Jun; 29(6):551-8. PubMed ID: 9635673 [TBL] [Abstract][Full Text] [Related]
8. Interleukin-1 system and sex steroid receptor gene expression in human endometrial cancer. Singer CF; Kronsteiner N; Marton E; Walter I; Kubista M; Czerwenka K; Schreiber M; Tschugguel W; Wieser F; Kubista E Gynecol Oncol; 2002 Jun; 85(3):423-30. PubMed ID: 12051868 [TBL] [Abstract][Full Text] [Related]
9. Messenger RNA determination of estrogen receptor, progesterone receptor, pS2, and plasminogen activator inhibitor-1 by competitive reverse transcription-polymerase chain reaction in human breast cancer. Tong D; Schneeberger C; Czerwenka K; Schmutzler RK; Speiser P; Kucera E; Concin N; Kubista E; Leodolter S; Zeillinger R Clin Cancer Res; 1999 Jun; 5(6):1497-502. PubMed ID: 10389938 [TBL] [Abstract][Full Text] [Related]
10. Normal and malignant human endometrium express immunohistochemically estrogen receptor alpha (ER-alpha), estrogen receptor beta (ER-beta) and progesterone receptor (PR). Mylonas I; Jeschke U; Shabani N; Kuhn C; Kriegel S; Kupka MS; Friese K Anticancer Res; 2005; 25(3A):1679-86. PubMed ID: 16033082 [TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor beta1 and the beta2/betacx isoforms in nonneoplastic endometrium and in endometrioid carcinoma. Chakravarty D; Srinivasan R; Ghosh S; Gopalan S; Rajwanshi A; Majumdar S Int J Gynecol Cancer; 2007; 17(4):905-13. PubMed ID: 17309672 [TBL] [Abstract][Full Text] [Related]
12. Expression of estrogen receptor coregulators in normal and malignant human endometrium. Kershah SM; Desouki MM; Koterba KL; Rowan BG Gynecol Oncol; 2004 Jan; 92(1):304-13. PubMed ID: 14751175 [TBL] [Abstract][Full Text] [Related]
13. Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation. Lau KM; LaSpina M; Long J; Ho SM Cancer Res; 2000 Jun; 60(12):3175-82. PubMed ID: 10866308 [TBL] [Abstract][Full Text] [Related]
14. Oestrogen receptors alpha and beta differ in normal human breast and breast carcinomas. Shaw JA; Udokang K; Mosquera JM; Chauhan H; Jones JL; Walker RA J Pathol; 2002 Dec; 198(4):450-7. PubMed ID: 12434414 [TBL] [Abstract][Full Text] [Related]
15. Coordinate expression of Cdc25B and ER-alpha is frequent in low-grade endometrioid endometrial carcinoma but uncommon in high-grade endometrioid and nonendometrioid carcinomas. Wu W; Slomovitz BM; Celestino J; Chung L; Thornton A; Lu KH Cancer Res; 2003 Oct; 63(19):6195-9. PubMed ID: 14559803 [TBL] [Abstract][Full Text] [Related]
16. Quantification of estrogen receptor alpha and beta expression in sporadic breast cancer. Bièche I; Parfait B; Laurendeau I; Girault I; Vidaud M; Lidereau R Oncogene; 2001 Dec; 20(56):8109-15. PubMed ID: 11781824 [TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor (ER) beta modulates ERalpha-mediated transcriptional activation by altering the recruitment of c-Fos and c-Jun to estrogen-responsive promoters. Matthews J; Wihlén B; Tujague M; Wan J; Ström A; Gustafsson JA Mol Endocrinol; 2006 Mar; 20(3):534-43. PubMed ID: 16293641 [TBL] [Abstract][Full Text] [Related]
18. Altered expression of ERs, aromatase, and COX2 connected to estrogen action in type 1 endometrial cancer biology. Jarzabek K; Koda M; Walentowicz-Sadlecka M; Grabiec M; Laudanski P; Wolczynski S Tumour Biol; 2013 Dec; 34(6):4007-16. PubMed ID: 23873111 [TBL] [Abstract][Full Text] [Related]
19. Steroid receptors ERalpha, ERbeta, PR-A and PR-B are differentially expressed in normal and atrophic human endometrium. Mylonas I; Jeschke U; Shabani N; Kuhn C; Kunze S; Dian D; Friedl C; Kupka MS; Friese K Histol Histopathol; 2007 Feb; 22(2):169-76. PubMed ID: 17149689 [TBL] [Abstract][Full Text] [Related]
20. Fatty acid synthase is a potential therapeutic target in estrogen receptor-/progesterone receptor-positive endometrioid endometrial cancer. Rahman MT; Nakayama K; Ishikawa M; Rahman M; Katagiri H; Katagiri A; Ishibashi T; Iida K; Miyazaki K Oncology; 2013; 84(3):166-73. PubMed ID: 23306391 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]